The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications

JR Allegretti, BH Mullish, C Kelly, M Fischer - The Lancet, 2019 - thelancet.com
Developments in high-throughput microbial genomic sequencing and other systems biology
techniques have given novel insight into the potential contribution of the gut microbiota to …

The promise of the gut microbiome as part of individualized treatment strategies

DA Schupack, RAT Mars, DH Voelker… - Nature reviews …, 2022 - nature.com
Variability in disease presentation, progression and treatment response has been a central
challenge in medicine. Although variability in host factors and genetics are important, it has …

Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization

FC Pereira, K Wasmund, I Cobankovic… - Nature …, 2020 - nature.com
Many intestinal pathogens, including Clostridioides difficile, use mucus-derived sugars as
crucial nutrients in the gut. Commensals that compete with pathogens for such nutrients are …

Establishing or exaggerating causality for the gut microbiome: lessons from human microbiota-associated rodents

J Walter, AM Armet, BB Finlay, F Shanahan - Cell, 2020 - cell.com
Human diseases are increasingly linked with an altered or" dysbiotic" gut microbiota, but
whether such changes are causal, consequential, or bystanders to disease is, for the most …

Main active components of Jiawei Gegen Qinlian decoction protects against ulcerative colitis under different dietary environments in a gut microbiota-dependent …

Q Li, Y Cui, B Xu, Y Wang, F Lv, Z Li, H Li… - Pharmacological …, 2021 - Elsevier
As an effective drug against acute enteritis diarrhea, Gegen Qinlian decoction (GQD) has a
history of 2000 years. However, the potential molecular mechanism through which GQD …

Mining the microbiota for microbial and metabolite-based immunotherapies

AN Skelly, Y Sato, S Kearney, K Honda - Nature Reviews Immunology, 2019 - nature.com
Trillions of microorganisms transit through and reside in the mammalian gastrointestinal tract
each day, collectively producing thousands of small molecules and metabolites with local …

Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota

JR Fletcher, CM Pike, RJ Parsons, AJ Rivera… - Nature …, 2021 - nature.com
Clostridioides difficile is a bacterial pathogen that causes a range of clinical disease from
mild to moderate diarrhea, pseudomembranous colitis, and toxic megacolon. Typically, C …

Longitudinal evaluation of fecal microbiota transplantation for ameliorating calf diarrhea and improving growth performance

HS Kim, TW Whon, H Sung, YS Jeong, ES Jung… - Nature …, 2021 - nature.com
Calf diarrhea is associated with enteric infections, and also provokes the overuse of
antibiotics. Therefore, proper treatment of diarrhea represents a therapeutic challenge in …

Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota

H Nagao-Kitamoto, JL Leslie, S Kitamoto, C Jin… - Nature medicine, 2020 - nature.com
The involvement of host immunity in the gut microbiota-mediated colonization resistance to
Clostridioides difficile infection (CDI) is incompletely understood. Here, we show that …

Bile acid-independent protection against Clostridioides difficile infection

AM Aguirre, N Yalcinkaya, Q Wu, A Swennes… - PLoS …, 2021 - journals.plos.org
Clostridioides difficile infections occur upon ecological/metabolic disruptions to the normal
colonic microbiota, commonly due to broad-spectrum antibiotic use. Metabolism of bile acids …